• News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • CEO Statement
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
  • Investors
    • Overview
    • Rights Issue / Företrädesemission 2022
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Company Presesentation
    • The Share
      • Share Information
      • Largest Shareholders
      • Share Capital Development
      • Rights Issues / Företrädesemissioner
      • Previous Share Issuances
      • Analyst Coverage
    • Financial Reports
      • English
      • Swedish
    • Financial Calendar
    • Corporate governance
      • General Meetings
      • Nomination Committee / Valberedning
      • Auditor
      • Articles of Association
      • Board of Directors
      • Management
    • Certified Adviser
    • IR Contact
  • Career
  • Contact
logo
  • News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • CEO Statement
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
  • Investors
    • Overview
    • Rights Issue / Företrädesemission 2022
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Company Presesentation
    • The Share
      • Share Information
      • Largest Shareholders
      • Share Capital Development
      • Rights Issues / Företrädesemissioner
      • Previous Share Issuances
      • Analyst Coverage
    • Financial Reports
      • English
      • Swedish
    • Financial Calendar
    • Corporate governance
      • General Meetings
      • Nomination Committee / Valberedning
      • Auditor
      • Articles of Association
      • Board of Directors
      • Management
    • Certified Adviser
    • IR Contact
  • Career
  • Contact
Home / Investors / Presentations
  • Overview
  • Rights Issue / Företrädesemission 2022
  • Press Releases
    • English
    • Swedish
    • Subscribe
  • Presentations
  • Company Presentation
  • The Share
    • Share Information
    • Largest Shareholders
    • Share Capital Development
    • Rights Issues / Företrädesemissioner
    • Analyst Coverage
  • Financial Reports
    • English
    • Swedish
  • Financial Calendar
  • Corporate Governance
    • General Meetings
    • Nomination Committee / Valberedning
    • Previous Nomination Committees
    • Auditor
    • Articles of Association
    • Board of Directors
    • Management
  • Certified Adviser
  • IR Contact

Presentations

All Investor presentations Scientific presentations
Investor presentations

2023-03-15

Alzheimer Panel Discussion

Kristina Torfgård, CEO, participated in Redeye's Alzheimer panel discussion. Read more

Scientific presentations

2022-12-02

Preclinical data presented at, Clinical Trials in Alzheimer’s Disease (CTAD) 2022

Dr. Anders Sandberg, Chief Scientific Officer, presented data for the Company's preclinical antibody candidate ALZ-201. The poster summarises the… Read more

Scientific presentations

2021-07-26

Preclinical data presented at Alzheimer’s Association International Conference (AAIC) 2021

Dr. Anders Sandberg, Chief Scientific Officer, presented data on the Company's monoclonal antibody, ALZ-201. The poster features preclinical data… Read more

Investor presentations

2022-12-15

Alzinova presented at Redeye Investor AW

Watch our CEO Kristina Torfgård, present Alzinova (in Swedish). Read more

Investor presentations

2022-11-16

CEO Kristina Torfgård at Mangold Insight investor day

On November 16, our CEO, Kristina Torfgård, presented at Mangold Insight investor day. Read more

Investor presentations

2022-10-24

Kristina Torfgård, our CEO, interviewed by Mangold Insight

Watch the new interview (in Swedish). Read more

Investor presentations

2022-10-12

Alzinova participated at Redeye Investor day, 12th of October 2022

Read more

Investor presentations

2022-06-08

Alzinova presented at BioStock Life Science Spring Summit 2022

On June 8, our CEO, Kristina Torfgård, presented at BioStock Life Science Spring Summit. Read more

Investor presentations

2022-06-03

Our CEO, Kristina Torfgård, at BioStock studio

Kristina visited Biostock's studio to talk about how Alzinova differs from other companies developing treatments for Alzheimer's disease. She… Read more

Investor presentations

2022-05-19

Mangold Insight’s interview with CEO Kristina Torfgård

Read more

Investor presentations

2022-06-02

Our CEO, Kristina Torfgård, at Redeye Growth Day 2022

Alzinova recently participated in the Redeye Growth Day 2 June 2022. Check out the Q&A session with our CEO,… Read more

Investor presentations

2022-05-18

CEO Presentation at AGM 18 May 2022

Read more

Investor presentations

2022-05-11

Alzinova at Aktieportföljen Live

Kristina Torfgård, our CEO, presented Alzinova at Aktieportföljen Live on May 11. Read more

Investor presentations

2022-05-03

Alzheimer Panel Discussion

Kristina Torfgård, CEO, participated in Redeye's Alzheimer panel discussion. Read more

Investor presentations

2022-02-03

Alzinova Team Presents at Redeye Transactions

Kristina Torfgård, CEO, Anders Sandberg, CSO, and Håkan Skogström, CFO, were interviewed by our Communications Specialist, Jamie Smith, at… Read more

Investor presentations

2022-01-26

Alzinova Presented at Mangold Insight Investment Day

On January 26, our CEO, Kristina Torfgård, presented Alzinova at Mangold Insight Life Science Investent day. Read more

Investor presentations

2022-01-14

Alzinova at RedEye Investor Forum Online

Our CEO, Kristina Torfgård presented Alzionva at RedEye Investor Forum Online on January 13. Read more

2022-01-12

Video Explainer Released

Like us, you probably know someone who has, or has had, Alzheimer’s disease. It is a progressively debilitating disease… Read more

Investor presentations

2021-12-16

Alzinova at Redeye Investor Forum Online

Watch our CEO Krisitna Torfgård present Alzinova at RedEye Investor Forum. Read more

Investor presentations

2021-11-24

Alzinova at Aktieportföljen

On November 24 our CEO Kristina Torfgård, presented Alzinova at Aktieportföljen. Read more

Investor presentations

2021-11-11

CEO Kristina Torfgård presented at Redeye Life Science Day

Read more

Investor presentations

2021-10-20

Redeye Interview with CEO Kristina Torfgård

Alzinova's CEO Kristina Torfgård was interviewed on October 13, 2021 by Redeye’s Life Science analyst Kevin Sule. Read more

Investor presentations

2021-10-13

Alzinova at Redeye Neurology (CNS) Seminar October 13th

Our CEO, Kristina Torfgård, presented the company at the Redeye Neurology Seminar together with representatives from the other Swedish… Read more

Investor presentations

2021-10-11

Alzinova presented at Aktiedagen Stockholm

Kristina Torfgård, CEO presented Alzinova at Aktiespararnas Aktiedag, October 11 2021. Read more

Investor presentations

2021-09-24

Alzinova presented at Redeye Investor Forum

CEO Kristina Torfgård presented at Redeye Investor Forum, September 23 2021. Read more

Investor presentations

2021-06-02

CEO Kristina Torfgård presented at Redeye Growth Day 2021

Read more

Investor presentations

2021-05-17

Alzinova presented at Aktiektiedagen Göteborg

Read more

Investor presentations

2021-05-05

Alzinova at the Captario Webinar

Read more

Investor presentations

2021-04-29

Alzinova Presented at Redeye Investor Forum April 29th

Read more

Investor presentations

Webcast with CEOs of Swedish Alzheimer’s companies

Our CEO, Kristina Torfgård, recently participated in a webcast discussion on Alzheimer's disease together with the CEOs of two… Read more

Investor presentations

2021-03-01

Redeye interview with CEO Kristina Torfgård

Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund. Read more

Scientific presentations

2020-11-04

Study design for the first clinical study with the oligomer-specific therapeutic vaccine ALZ-101 presented at Clinical Trials in Alzheimer’s Disease (CTAD) 2020

Alzinova presented the study design of the upcoming first clinical study with the oligomer-specific therapeutic vaccine ALZ-101 on a… Read more

Investor presentations

2020-10-15

Redeye Neurology Seminar CNS, October 15, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Redeye's Neurology Seminar CNS on October 15 - in Swedish… Read more

Investor presentations

2020-10-06

Investor Presentation, October 6, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Redeye Investor Forum Special - in Swedish… Read more

Investor presentations

2020-10-01

Investor Presentation, October 1, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Redeye Investor Forum - in Swedish… Read more

Investor presentations

2020-09-29

Alzinova – About the Preferential Rights Issue

Kristina Torfgård, CEO talks briefly about the Preferential Rights issue in Redeye's "transaction pitch" - in Swedish. Read more

Investor presentations

2020-09-29

Alzinova – About the Company

Kristina Torfgård, CEO talks briefly about the company in Redeye's "Company pitch" - in Swedish. Read more

Investor presentations

2020-09-29

Alzinova – Elevator Pitch

Kristina Torfgård, CEO talks briefly about the company in Redeye's "elevator pitch" - in Swedish. Read more

Investor presentations

2020-09-29

Investor Presentation, September 29, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at the Redeye Investor Event - in Swedish… Read more

Investor presentations

2020-09-21

Aktiespararnas Aktiedag, September 21, 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at Aktiespararnas Aktiedag, September 21 2020 - World Alzheimer's Day… Read more

Scientific presentations

2020-07-30

Preclinical data presented at Alzheimer’s Association International Conference (AAIC) 2020

Dr. Anders Sandberg, Chief Scientific Officer, presented data on the Company's substances. The poster provides an overview of the… Read more

Investor presentations

Redeye interview with CEO Kristina Torfgård – webcast (in Swedish)

Alzinova's CEO Kristina Torfgård was interviewed on March 3, 2020 by Redeye’s Life Science analyst Anders Hedlund. Read more

Investor presentations

Redeye Growth Day, June 2 2020 – webcast presentation (in Swedish)

Kristina Torfgård, CEO presented Alzinova at the Redeye Growth Day, Sweden. Read more

  • News
  • Our Company
  • Patients & Families
  • R & D
  • Investors
  • Contact

Alzinova AB. Pepparedsleden 1, SE-431 83, Mölndal, Sweden
+46 (0) 708 467 975   info@alzinova.com

Follow us on

follow us on linkedin